These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9170469)

  • 41. Comparison of triple-risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free beta-subunit (free beta hCG).
    Sancken U; Bahner D
    Fetal Diagn Ther; 2003; 18(2):122-7. PubMed ID: 12576748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes.
    Sirikunalai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
    J Obstet Gynaecol; 2016; 36(2):178-82. PubMed ID: 26368010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
    Rudnicka AR; Wald NJ; Huttly W; Hackshaw AK
    Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
    Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
    Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
    Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.
    Nunthapiwat S; Sekararithi R; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    Gynecol Obstet Invest; 2019; 84(4):326-333. PubMed ID: 30602167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urine free beta-hCG and total estriol for Down syndrome screening during the second trimester in an Asian population.
    Hsu JJ; Hsu TY; Hsieh TT; Soong YK; Hsieh FJ; Spencer K
    Obstet Gynecol; 1999 Jul; 94(1):107-11. PubMed ID: 10389728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined screening for open spina bifida at 11-13 weeks using fetal biparietal diameter and maternal serum markers.
    Bernard JP; Cuckle HS; Bernard MA; Brochet C; Salomon LJ; Ville Y
    Am J Obstet Gynecol; 2013 Sep; 209(3):223.e1-5. PubMed ID: 23673229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG.
    Casals E; Fortuny A; Grudzinskas JG; Suzuki Y; Teisner B; Comas C; Sanllehy C; Ojuel J; Borrell A; Soler A; Ballesta AM
    Prenat Diagn; 1996 May; 16(5):405-10. PubMed ID: 8843997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
    Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
    Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
    Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free beta-hCG.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):648-51. PubMed ID: 10951475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP.
    Barnabei VM; Krantz DA; Macri JN; Larsen JW
    Prenat Diagn; 1995 Dec; 15(12):1131-4. PubMed ID: 8750293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of abnormal triple screen for Down syndrome is significantly higher in patients with female fetuses.
    Spong CY; Ghidini A; Stanley-Christian H; Meck JM; Seydel FD; Pezzullo JC
    Prenat Diagn; 1999 Apr; 19(4):337-9. PubMed ID: 10327139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin.
    Palacio M; Jauniaux E; Kingdom J; Dell E; Sheldrake A; Rodeck CH
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):58-62. PubMed ID: 10201088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum marker screening during the second trimester for prenatal diagnosis and predicting pregnancy outcome].
    Yang L; Zhao L; Jiang J; Liu J; Tao H; Wang J; Wu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):1059-62, 1072. PubMed ID: 26198962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chromosomal abnormalities and adverse pregnancy outcome with maternal serum second trimester triple screening test for fetal Down syndrome in 4,860 Chinese women.
    Xia YP; Zhu MW; Li XT; Zhou HP; Wang J; Lv JX; Zhong N
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 38(1):49-52. PubMed ID: 16415966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.